Court Grants Injunction In Epilepsy Drug Patent Case

Law360, New York (October 24, 2006, 12:00 AM EDT) -- OrthoMcNeil Neurologics Inc. won an injunction on Monday against generics producer Mylan Laboratories Inc., blocking the release of a generic form of the blockbuster epilepsy drug until a final court decides on the validity of the Topamax patent.

Judge Stanley Chesler of the U.S. District Court for the District of New Jersey granted Johnson & Johnson subsidiary OrthoMcNeil’s request for an injunction over the sale of topiramate, the medical name for anticonvulsant drug Topamax.

The preliminary injunction will be in effect until the district court has...
To view the full article, register now.